Typhim Vi 25 ug/.5mL
SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN · INJECTION, SOLUTION · Sanofi Vaccines US Inc.
Typhim Vi is a injection, solution containing salmonella typhi ty2 vi polysaccharide antigen at 25 ug/.5mL, taken intramuscular. Manufactured by Sanofi Vaccines US Inc..
Key Facts
- Brand Name
- Typhim Vi
- Generic Name
- SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
- NDC Code (Product)
49281-790- Manufacturer
- Sanofi Vaccines US Inc.
- Strength
- 25 ug/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA103936
- Marketing Start
- 11/28/1994
Recall History
No Recall HistoryFrequently Asked Questions
What is Typhim Vi used for?
Typhim Vi contains SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is Typhim Vi a controlled substance?
Typhim Vi is not classified as a controlled substance by the DEA.
What is the generic name for Typhim Vi?
The generic name for Typhim Vi is SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN. There are 1 other brand versions of SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN.
What is the NDC code for Typhim Vi 25 ug/.5mL?
The NDC (National Drug Code) for Typhim Vi 25 ug/.5mL is 49281-790, listed by Sanofi Vaccines US Inc..